A pilot study involving 7 children with Cerebral Palsy treated with umbilical cord stem cells has shown: (1) No rejection or adverse reaction issues; (2) Clinically and statistically signficant improvements in a number of areas of function.
San Clemente, CA (PRWEB) August 31, 2004 -- A pilot study involving 7 children with Cerebral Palsy treated with umbilical cord stem cells abroad has shown: (1) No rejection or adverse reaction issues; (2) Clinically and statistically significant improvements in a number of physical and mental functions.
During 2003 seven (7) children with Cerebral Palsy were treated with pure umbilical cord stem cells as part of a pioneering pilot study. No immunosuppressant drugs were given and no rejection or adverse reactions occurred (No Host v. Graft or Graft v. Host).
The Steenblock Research Institute (a California non-profit corporation) has systematically documented and analyzed the physical and mental responses of these children. Most have shown decreased spasticity and various kinds and degrees of motor skill and cognitive improvement. Analysis of specially designed questionnaires completed by parents and caregivers has shown statistically significant improvements in such areas of function as muscle tone, leg movement, hip movement, thinking and understanding.
These responses were underscored by corroborative evaluation reports and statements tendered by pediatricians, pediatric neurologists, physical therapists, teachers, and others involved in the care of many of these children. In addition, most of the parents videotaped or photographed their children at regular intervals prior to and following umbilical cord stem cell therapy. This visual record has lent added weight to SRI's findings.
One of the most spectacular responses in the study was a very young boy who was cortically blind prior to umbilical cord stem cell therapy. Five months following treatment he began to track objects with his eyes.
Just as remarkable was the response of 4 year old little girl with microcephaly (i.e, abnormally small head size) who experienced significant head growth in the six months immediately following treatment with umbilical cord stem cells. Her father remarked that, This is the most it has grown in years. One of Sarah's neurologists confirmed this measurement and was very pleased with the growth. I am also very, very pleased!"
A formal paper based on SRIs findings has been submitted to the peer-reviewed journal, "Cell Transplantation."
# # #
|
